Legal Research

Parenting Plan Contempt Affirmed Under RCW 26.09.160

The Court of Appeals of Washington, Division One affirmed a contempt finding against Adrienne LaFlam for failing to return her children to Colm Gent on Monday August 12, 2024 and Monday August 26, 2024, in violation of Phase I of their court-ordered parenting plan. The court imposed a $100 civil penalty payable to Gent and awarded 12 overnights of make-up visitation. LaFlam challenged the contempt finding, arguing insufficient evidence of willfulness and improper mandatory sanctions, but the appellate court found no abuse of discretion by the King County Superior Court under RCW 26.09.160.

Nies v. Cement Distributors Inc. - Breach of Fiduciary Duty

The Washington Court of Appeals reversed and remanded the trial court's judgment in Nies v. Cement Distributors Inc., finding the lower court erred in interpreting the Shareholders' Agreement and Transfer of Shares to Corporation (STA) document signed by former CFO Gordon Nies in September 2016. Nies was found to have breached his fiduciary duty as CDI's CFO by filing false Form 940 and 941 tax returns for 2006, 2008, 2011, and 2012, and by failing to transfer withheld employee paychecks to the IRS and Canadian Revenue Agency. CDI had sought recovery exceeding US$1,079,646.95 and Canadian$299,049.72 in damages.

K.B. v. Washington Affirms 14-Day Involuntary Mental Health Commitment

K.B., an unhoused individual with bipolar disorder and substance use history, appealed a 14-day involuntary mental health commitment order under the Involuntary Treatment Act. The Court of Appeals of Washington, Division One, rejected K.B.'s sufficiency-of-the-evidence challenge, holding that the trial court properly found the State proved by a preponderance of the evidence that K.B.'s mental disorder caused deterioration in routine functioning, putting her in danger of serious physical harm due to an inability to provide for essential human needs of health or safety. The court found K.B.'s testimony about her ability to function in the community was not persuasive because she had previously failed to secure and maintain access to shelter resources.

Terwilliger Guardianship, Home Sale, Protection Order Affirmed on Appeal

The Washington Court of Appeals Division One affirmed lower court rulings in consolidated appeal Nos. 87022-0-I, 87401-2-I, 87529-9-I, and 87530-2-I involving 90-year-old Lucille Terwilliger. The court upheld: the sale order authorizing Ohana Fiduciary Corporation to sell Terwilliger's home to cover her increased medical expenses; Ohana's appointment as Terwilliger's full guardian and conservator; the cancellation of Sheehan's lis pendens on the property; and the vulnerable adult protection order against Sheehan. The appeals court rejected appellant William Sheehan's challenges to all four proceedings and awarded Ohana its attorney fees.

Bedell v. Iles, Division I, Filed 13th Apr

Bedell v. Iles, Division I, Filed 13th Apr

In re Marriage of Morris - Divorce Appeal

The Washington Court of Appeals Division III filed an opinion in the marital dissolution appeal of Charletta D. Morris and Michael Scott Morris on April 14, 2026. The appeal, docketed as No. 40978-3, arose from Spokane County Superior Court Docket No. 20-3-01470-1, with the underlying judgment entered on January 17, 2025. The three-judge panel comprised Robert Lawrence-Berrey (author), Tyson Hill, and Tracy Staab, with counsel representing both sides.

List of Exempt Native Specimens Amendment (Victorian Abalone Fishery) Instrument 2026

The List of Exempt Native Specimens Instrument 2001 has been amended to include the Victorian Abalone Fishery as an exempt native specimen under the amendment instrument. This legislative amendment was made on 16 April 2026 and is administered by the Department of Climate Change, Energy, the Environment and Water. The amendment affects commercial abalone fishing operations in Victoria by adding the fishery to the list of specimens exempt from certain regulatory requirements.

Higher Education Support Legislation Amendment Enables Disclosure to 31 Agencies

The Higher Education Support Legislation Amendment (Disclosure of Information to Certain Agencies) Instrument 2026 (F2026L00433) amends the Higher Education Support (Administration) Guidelines 2022 by expanding the list of agencies authorised to receive information under the higher education funding scheme. The instrument adds Part 9, section 31, specifying 31 agencies to which information may be disclosed, and supersedes the Higher Education (Disclosure of Information to Other Bodies) Determination 2023. The amendment is administered by the Australian Department of Education and came into force on 16 April 2026.

Veterans' Entitlements Non-warlike Service Determination 2019

This legislative instrument determines what constitutes 'non-warlike service' for the purposes of the Veterans' Entitlements Act 1986. The instrument contains sections on authority, definitions, and a schedule listing specific non-warlike service classifications. The latest compilation (F2026C00323) was dated 09 April 2026, indicating ongoing amendment history.

Maritime Ship Station Class Licence 2025

The Maritime Ship Station Class Licence 2025 (Compilation No. F2026C00318, effective 17 March 2026) is a federal class licence made under the Radiocommunications Act 1992, administered by the Department of Infrastructure, Transport, Regional Development, Communications, Sport and the Arts. The instrument establishes the licensing framework for maritime ship stations operating radiocommunications equipment. Maritime operators and shipping companies using radio apparatus on vessels in Australian waters and on international voyages must operate in accordance with the conditions specified in this class licence, which removes the need for individual licences where the station meets the prescribed technical and operational standards.

Biosecurity First Point of Entry Port of Sydney Determination 2019

The Biosecurity (First Point of Entry—Port of Sydney) Determination 2019 designates the Port of Sydney as a first point of entry for biosecurity purposes under the Biosecurity Act 2015, administered by the Department of Agriculture, Fisheries and Forestry. The instrument establishes biosecurity entry points for vessels and goods, and sets conditions requiring operators to notify the Agriculture Department of relevant changes. This latest version (F2026C00319, 27 March 2026) incorporates amendments to the original 2019 determination.

Industry Research and Development (Carbon Capture Technologies Program) Instrument 2023

The Industry Research and Development (Carbon Capture Technologies Program) Instrument 2023 establishes a prescribed program under the Industry Research and Development Act 1986 for carbon capture technologies research and development. The instrument is administered by the Department of Industry, Science and Resources and specifies eligibility criteria that entities must satisfy to participate in the program. This legislative instrument is in force and carries the authorization of the Industry Research and Development Act 1986 as its enabling legislation.

Radiocommunications Maritime Ship Licence Conditions Determination 2025

This Determination establishes the mandatory conditions that apply to maritime ship radio licences under the Radiocommunications Act 1992. It sets out the technical, operational and administrative requirements that ship owners and maritime operators must satisfy to obtain and hold a maritime ship radio licence in Australia. Affected parties should review the conditions to ensure their current and future licensing arrangements comply with the new requirements.

National Health (Highly Specialised Drugs Program) Special Arrangement 2021

The National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (F2026C00321) is a compiled legislative instrument under the National Health Act 1953, administered by the Department of Health, Disability and Ageing, governing the supply, prescribing, and payment arrangements for highly specialised drugs (HSD) pharmaceutical benefits. The instrument establishes conditions for approved hospital authorities, approved pharmacists, and approved medical practitioners participating in the program, including prescription circumstances, maximum quantities and repeats, dispensing prices, and payment rates for public hospitals. Affected parties — hospital authorities, pharmacists, medical practitioners, and patients — must ensure compliance with the updated instrument upon its April 2026 compilation date.

Commonwealth v. Arias - 24-Hour Traffic Stop Delay Unreasonable Under Article 14

The Massachusetts Supreme Judicial Court reversed the denial of a motion to suppress evidence obtained during a traffic stop conducted 24 hours after police observed the defendant commit a civil traffic infraction while conducting a drug investigation surveillance. The court held that the motor vehicle stop violated Article 14 of the Massachusetts Declaration of Rights because the Commonwealth did not carry its burden to show the twenty-four hour delay was reasonable under the totality of the circumstances. The defendant's conviction for trafficking eighteen to thirty-six grams of cocaine was vacated and the matter remanded to Superior Court.

Mireille Pélissier-Simard Appointed to Superior Court of Quebec

Mireille Pélissier-Simard has been appointed as a Judge of the Superior Court of Quebec for the district of Québec, effective April 10, 2026. Justice Pélissier-Simard, previously Counsel and Family Mediator at Verdon Armanda Gauthier avocats since 2004, replaces Justice D. Dumais, who was appointed Senior Associate Chief Justice of the Superior Court of Quebec on November 8, 2025. The appointment was announced by the Honourable Sean Fraser, Minister of Justice and Attorney General of Canada, under the judicial application process established in 2016, which emphasizes transparency, merit, and diversity.

Minister Announces Two Judicial Appointments in Quebec Province

Minister of Justice Sean Fraser announced two judicial appointments in Quebec on March 27, 2026. Justice Andres C. Garin was elevated from the Superior Court of Quebec to the Court of Appeal of Quebec in Montréal, replacing Justice M.J. Hogue who resigned effective February 1, 2026. Stéphane Richer, a partner at Borden Ladner Gervais LLP, was appointed to fill Justice Garin's former position on the Superior Court of Quebec, effective March 25, 2026. These appointments were made under the 2016 judicial application process emphasizing transparency, merit, and diversity.

Appoints Amiram Y. Kotler as Judge, Court of King's Bench of Manitoba

Justice Amiram Y. Kotler has been appointed a Judge of the Court of King's Bench of Manitoba in Winnipeg, effective March 27, 2026. Justice Kotler, formerly Crown Attorney at the Government of Manitoba, replaces Justice G.L. Chartier, who elected to become a supernumerary judge effective January 5, 2026. The appointment was made under the judicial application process established in 2016, which emphasizes transparency, merit, and diversity in judicial appointments. For parties practicing before the Court of King's Bench of Manitoba, this represents a change in judicial assignment. The appointment does not alter court procedures or legal standards but will affect case scheduling and assignment as the new judge assumes duties.

Five Judicial Appointments Announced in Ontario Superior Court

The Minister of Justice and Attorney General of Canada announced five judicial appointments to the Superior Court of Justice of Ontario on March 27, 2026. Appointed were Justices Scott G. Pratt (Windsor), Cheryl C.M. Siran (Kenora), Constance Nielsen (Oshawa Family Court), Stephanie J. Ouellette (London Family Court), and Sean D.R. Heeley (Hamilton Family Court). Each appointment replaces a prior judge who either became a supernumerary judge or resigned, with effective dates ranging from March to November 2025.

Four Judicial Appointments Announced in British Columbia

The Honourable Sean Fraser, Minister of Justice and Attorney General of Canada, announced four judicial appointments to the Supreme Court of British Columbia on March 27, 2026. Delaram Jahani and Jacqueline G. McQueen were appointed from the Provincial Court of BC, while Michael P. Klein, K.C. and Brook J. Greenberg, K.C. were appointed from legal practice. These appointments fill vacancies created when Justices Warren, Mayer, Brundrett, and Francis were elevated to the Court of Appeal for British Columbia.

Bispecific Anti-TRAILR2 and Anti-CDH17 Binding Molecules for Cancer Treatment - EP3559040A2

The EPO published patent application EP3559040A2, filed by Boehringer Ingelheim International GmbH, covering bispecific binding molecules that simultaneously target TRAILR2 (TNF-related apoptosis-inducing ligand receptor 2) and CDH17 (cadherin 17) for the treatment of cancer. The patent application was published on April 8, 2026 and is classified under IPC categories C07K 16/28, A61K 39/395, A61P 35/00, and C12N 15/62. The application designates all EPO contracting states covering major European pharmaceutical markets.

Polyglutamated Antifolates and Uses Thereof (EP3496757A1)

The European Patent Office published patent application EP3496757A1 for polyglutamated antifolates and their therapeutic uses, filed by L.E.A.F Holdings Group LLC. The patent covers compositions for treating cancer and inflammatory conditions. The application was published April 8, 2026, designating 36 European states including Germany, France, the United Kingdom, Italy, Spain, and other EU member states. No compliance deadlines or penalties are specified.

Bi-Specific Cancer Treatment Constructs with Different Epitope Binding

The European Patent Office published patent application EP3484516A1 assigned to Fred Hutchinson Cancer Center on April 8, 2026. The patent covers bi-specific binding domain constructs with different epitope binding properties for treating cancer. The technology falls under IPC classifications A61K 39/395, C07K 16/28, and C12N 15/09, with designated states covering major European markets.

Fibrous Dosage Form EP3500242A1

The European Patent Office published patent application EP3500242A1 titled 'Fibrous Dosage Form' on April 8, 2026. The patent application, filed by applicant Aron H. Blaesi with inventors Blaesi and Nannaji Saka, covers pharmaceutical dosage formulations classified under IPC A61K. The application designates multiple European member states for patent protection.

Novel Recombinant Protein UK114 in Stable Polymer Form for Tumour Treatment

The European Patent Office granted Patent EP3554639A1 to Alberto Bartorelli Cusani for a novel recombinant protein UK114 in stable polymer form designed for the treatment or prevention of malignant solid and systemic tumours. The patent covers pharmaceutical compositions containing the recombinant protein and methods of treatment. The patent is classified under A61K 38/50 and related pharmaceutical categories.

Immunoglobulin antibody against RSV prefusion F protein, published 8th Apr

Immunoglobulin antibody against RSV prefusion F protein, published 8th Apr

TLR4 Antagonist Patent for Multiple Myeloma Treatment EP3558323A1

The European Patent Office granted patent EP3558323A1 for specific TLR4 antagonists in the treatment of multiple myeloma. The patent applicants include Etablissement Français du Sang, CNRS, Université Paul Sabatier Toulouse III, and INSERM. Designated states cover all EU member states plus other EPC contracting states.

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

The European Patent Office granted Patent EP3244930A1 to the University of Southern California on April 8, 2026. The patent covers pharmaceutical compositions comprising POH derivatives for therapeutic applications including cancer treatment. The patent is designated across 38 European member states including DE, FR, GB, IT, ES, NL, BE, and others.

EP3283091A1 - Berry Extraction Method Using Alkaline Magnesium Compound

The European Patent Office granted Patent EP3283091A1 to inventor Reijonen, Mika Tapio. The patent covers a method of extracting berries or fruits using an alkaline magnesium compound for use in pharmaceutical, herbal, nutritional, or cosmetic ingredients. The patent is valid in 38 designated European states.

Oligonucleotides for Inducing Paternal UBE3A Expression - Angelman Syndrome Treatment

USPTO granted patent US12596118B2 to Hoffmann-La Roche Inc. covering oligonucleotides capable of inducing expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele for treatment of Angelman syndrome. The 30 claims target the suppressor of the UBE3A paternal allele via hybridization to SNHG14 long non-coding RNA downstream of SNORD109B.

HM Land Registry Business Plan 2026+ Roadmap

HM Land Registry published its 2026+ Business Plan on 31 March 2026, setting out strategic priorities for investment in services, technology, data, and workforce development across England and Wales. The plan covers Strategy 25+, key performance indicators, risk profile, and financial planning for the registration service. While this document provides insight into future service improvements and modernisation initiatives, it does not impose any immediate compliance obligations on property professionals, conveyancers, or consumers.

Novel Anti-inflammatory Compounds - EP3759089A1

The European Patent Office published patent application EP3759089A1 for novel anti-inflammatory compounds developed by Inflazome Limited. The patent covers compounds classified under C07D 401/12 with therapeutic applications (A61P 29/00). Validated in designated contracting states including Germany, France, United Kingdom, Italy, Spain, and other EU member states.

EP3759090A1 Novel Therapeutic Compounds by Inflazome Limited

The European Patent Office published patent application EP3759090A1 for novel therapeutic compounds filed by Inflazome Limited. The patent covers heterocyclic compounds with IPC classifications including C07D derivatives and A61P therapeutic activity (anti-inflammatory/analgesic). Designated states include all EU member states plus associated countries. The publication marks the grant of patent rights for these novel compounds.

Methods for Using Low-Dose Colchicine After Myocardial Infarction (EP3821909A1)

The European Patent Office published application EP3821909A1, titled 'Methods for Using Low-Dose Colchicine After Myocardial Infarction.' The application, filed by Institut de Cardiologie de Montréal, claims methods of treating patients with low-dose colchicine following myocardial infarction. The published application covers 38 designated European states.

Use of Chimeric Antigen Receptor-Modified T Cells to Treat Cancer

The European Patent Office granted Patent EP3660029A1 to The Trustees of the University of Pennsylvania covering chimeric antigen receptor (CAR)-modified T cells for cancer treatment. The patent names inventors Carl H. June, Bruce L. Levine, David L. Porter, Michael D. Kalos, and Michael C. Milone. The patent covers methods for treating cancer using CAR-modified T cells, with designations extending across 35 European states.

INHIBITORS OF TRPC6 - Boehringer Ingelheim International GmbH

The European Patent Office published patent application EP3752503A1 for TRPC6 inhibitors assigned to Boehringer Ingelheim International GmbH. The patent covers therapeutic compounds for cardiovascular, respiratory, and neurological applications. The application designates all EPC contracting states including Germany, France, United Kingdom, Italy, and Spain.

Applauds General Assembly for Passing Student Physical Privacy Act

South Carolina Attorney General Alan Wilson issued a statement on April 15, 2026, applauding the passage of H.4756, the Student Physical Privacy Act, by the South Carolina General Assembly. Wilson called the legislation a necessary step to protect women's and girls' privacy and safety in gender-separated spaces such as bathrooms and locker rooms. The bill is awaiting ratification and transmittal to the Governor for his signature.

In Re: Nomination of Griffith; Appeal of: Thelma Peake

The Pennsylvania Supreme Court denied Appellant Thelma Peake's Application for Leave to File Brief Nunc Pro Tunc and quashed her Notice of Appeal in the matter concerning Shaun Griffith's nomination petition for Pennsylvania's 3rd Congressional District. The court disposed of the case on procedural grounds, finding that Peake failed to file a timely brief. The ruling limits Peake's ability to challenge Griffith's nomination petition and underscores that strict compliance with appellate filing deadlines is required.

EP3977697A1 - Method and Apparatus for Scheduling Terminal Devices

The European Patent Office published patent application EP3977697A1 by Telefonaktiebolaget LM Ericsson (publ) for a method and apparatus to schedule terminal devices in telecommunications networks. The patent covers innovations in scheduling terminal devices using various H04L and H04W classification technologies. Inventors are Chunhui Liu, Yongqian Chen, and Bin Li.

NTT DOCOMO Terminal and Communication Method Patent EP4027720A1

The European Patent Office published patent application EP4027720A1 for NTT DOCOMO's terminal and communication method technology. The patent relates to wireless communications systems classified under H04W and H04L. The application designates multiple European member states including Germany, France, United Kingdom, Italy, and Spain.

Avalos v. Dr. Ashby et al - Summary Judgment Granted

Judge Rita F. Lin of the U.S. District Court for the Northern District of California granted the defendant's motion for summary judgment in Avalos v. Dr. Ashby et al, case number 3:24-cv-05581-RFL, dismissing all claims against the defendant. The order was signed on April 14, 2026, and filed on April 15, 2026. As a result, the plaintiff's claims in this prisoner civil case are resolved without trial.

Nelson v. Discord, Inc. - TCPA Civil Complaint

Justin Nelson filed a civil complaint against Discord, Inc. in the Northern District of California on April 15, 2026, alleging violations of the Telephone Consumer Protection Act (TCPA). The complaint was filed with a $405 filing fee (receipt number ACANDC-21874911). Three documents were filed on the same date: the complaint, a proposed summons, and a certificate of interested entities. Attorney Dana Oliver represents the plaintiff. This is an early-stage filing; no court rulings, motions, or substantive orders have been issued.

Legacy Investments Holdings LLC v. John Does 1-20 – Administrative Motion to File Under Seal

A civil fraud case pending before the U.S. District Court for the Northern District of California shows two recent procedural filings. On April 16, 2026, Legacy Investments Holdings, LLC filed its tenth administrative motion to seal portions of the first amended complaint containing newly discovered facts. On April 15, 2026, the same plaintiff filed an administrative motion to file a first amended complaint, with responses due by April 20, 2026. Both filings are linked to Case No. 3:25-cv-08800-RFL before Judge Rita F. Lin in San Francisco.

AI Measures Net Gain Loss for Uncertain Events Using Monte Carlo Simulations

The USPTO published patent application US20260099795A1 titled 'System and a Method for Measuring Net Gain and Loss of Alternatives for Uncertain Events.' The application, filed by inventor Ernest Forman on August 31, 2024, discloses an AI system that receives uncertain events, alternatives, objectives, and certain events, then uses Monte Carlo simulations on evaluated likelihoods and consequences to determine expected loss or gain for each alternative. This is a routine USPTO publication of a patent application in the decision-support software field.

Metadata Centric AI Class Reassignment Patent

USPTO published patent application US20260099765A1 for a metadata-centric AI system that reassigns data classifications based on performance metrics and confusion matrix analysis. The invention derives group-specific thresholds from prior classification instances to evaluate and update predicted classifications. Inventors include Madhusoodhana Chari Sesha, Pradeep Kumar Surenran, Ankush Anshuman, Akshay Jain, and Surya Thankamony Somanathan.

Computing User-Specific Item Prices Using AI

USPTO published patent application US20260099858A1 by inventors Veijo Heinonen and Mikko Saikko disclosing a method and apparatus for calculating user-specific item prices using artificial intelligence. The system determines personalized pricing based on user attribute profile vectors, item attribute vectors, price elasticity metrics, and appeal scores. The application (No. 19416874) was filed on December 11, 2025.

Integrated Customer Intelligence Platform and Method

The USPTO has granted Patent Application US20260099856A1 to Kyocera Document Solutions Inc. for an integrated customer intelligence platform and method in document management systems. The system collects customer market data including characteristics, engagement status, and usage patterns to generate actionable recommendations using predictive heuristics models with cyclicality and seasonality probability scoring. Inventors include Selim ZAMAN.

Motion to Proceed to H.J.Res. 140 Passes 51-49, April 15, 2026

The US Senate voted 51-49 on April 15, 2026, to invoke cloture on the motion to proceed to H.J.Res. 140, advancing the resolution to floor debate. The motion required a simple majority (1/2) and passed with 51 affirmative votes against 49 dissenting votes. This procedural vote allows the Senate to begin consideration of H.J.Res. 140 on the floor.

Senate Rejects Motion to Discharge Israel Arms Sale Disapproval Resolution 36-63

The Senate rejected a motion to discharge S.J.Res. 138, a joint resolution that would have provided for congressional disapproval of a proposed foreign military sale to the Government of Israel of certain defense articles and services. The vote fell 36-63 with one senator not voting, failing to achieve the simple majority required. With the discharge motion rejected, the underlying resolution remains stalled in the Senate Foreign Relations Committee and cannot advance to the floor for a vote on the merits.

Motion to Table H.J.Res. 140 Passes, 51-48

The US Senate voted 51-48 on April 15, 2026, to agree to a Motion to Table H.J.Res. 140, specifically the Submitted Point of Order Re: H.J.Res. 140. The procedural motion passed with a simple majority, with 51 YEAs (all Republicans plus 2 Independents), 48 NAYs (all Democrats), and 1 Not Voting (Tillis, R-NC). By tabling the resolution, the Senate effectively set aside further consideration of H.J.Res. 140 for this legislative session.